As of 12:03pm ET
| -0.01 / -0.25%|
The 5 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 9.00 and a low estimate of 4.00. The median estimate represents a +50.00% increase from the last price of 4.00.
The current consensus among 9 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.